$17.40
0.462.72%
Last update: Oct 28, 3:40 PM
ASTELLAS PHARMA INC by Astellas Pharma, Inc. (ALPMF) Stock Price, Quote, News & History
ALPMFOTCPK
European committee backs Merck's Keytruda + Padcev combo for bladder cancer after Phase 3 trial slashes risk of recurrence by 47%.
You can purchase shares of ASTELLAS PHARMA INC by Astellas Pharma, Inc. (OTCPK:ALPMF) through any online brokerage.
There are no as such competitors for ASTELLAS PHARMA INC by Astellas Pharma, Inc..
There is no analysis for ASTELLAS PHARMA INC by Astellas Pharma, Inc. to provide a consensus price target.
The stock price for ASTELLAS PHARMA INC by Astellas Pharma, Inc. (OTCPK: ALPMF) is $17.4 last updated October 28, 2026 at 3:40 PM EDT.
There are no upcoming dividends for ASTELLAS PHARMA INC by Astellas Pharma, Inc..
ASTELLAS PHARMA INC by Astellas Pharma, Inc. does not have any upcoming earnings scheduled.
There is no upcoming split for ASTELLAS PHARMA INC by Astellas Pharma, Inc..
ASTELLAS PHARMA INC by Astellas Pharma, Inc. is in the Health Care sector and Pharmaceuticals industry. They are listed on the OTCPK.
Astellas Pharma Inc is a specialty international pharmaceutical company. The company focuses on accelerating the discovery, development, and commercialization of ground-breaking innovations that could redefine expectations of care for...
